Related Experiment Videos

Post streptococcal myalgia: an under-recognized clinical syndrome

Thirunavukkarasu Arun Babu1, Chandrasekaran Venkatesh

  • 1Department of Pediatrics, Sri Lakshmi Narayana Institute of Medical Sciences (SLIMS), Osudu, Agaram Village, Puducherry 605 502, India. babuarun@yahoo.com

Indian Journal of Pediatrics
|June 23, 2011
PubMed

Insights

Post-streptococcal myalgia (PSM) is a rare complication of streptococcal infections in children. Consider PSM in pediatric patients with sudden muscle pain and elevated Anti-Streptolysin O titers.

Area of Science:

  • Pediatric Rheumatology
  • Infectious Disease Complications
  • Autoimmune Sequelae

Background:

  • Post-streptococcal myalgia (PSM) is an under-recognized non-infectious sequela of streptococcal infections.
  • Prompt diagnosis and management are crucial for pediatric patients.

Observation:

  • A case report details an 11-year-old boy diagnosed with PSM.
  • The case involved acute onset of severe muscle pain following a streptococcal infection.

Findings:

  • The study reviews previously reported cases of PSM in children.
  • Elevated Anti-Streptolysin O (ASO) titers were a key diagnostic indicator.
  • PSM diagnosis should be considered in children with acute myalgia and high ASO levels.

Implications:

  • Highlights the importance of recognizing PSM in pediatric practice.
  • Suggests a need for increased awareness among clinicians regarding this non-infectious complication.
  • Emphasizes the diagnostic utility of ASO titers in suspected PSM cases.

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...